Prime researchers found that the CAR T cohort had a significantly higher average total cost of care compared with the BiTE cohort: $702,000 vs. $372,000. Among the studied therapies, drug costs were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback